Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

From Dupixent to Tezspire and verekitug, explore emerging sinusitis treatments and the race to improve chronic rhinosinusitis ...

Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to ...

Stay updated on biotech layoffs in 2026! Each week, we track and analyze industry layoffs, their causes, and their impact.

CRISPR technology offers the promise to cure human genetic diseases with gene editing. This promise became a reality when the world’s first CRISPR therapy was approved by regulators to treat patients ...

How does chronic hepatitis B affect a person’s daily life? Although acute hepatitis B infections generally resolve within six months and do not require treatment, chronic infections – meaning the ...

Amyotrophic lateral sclerosis (ALS) remains one of the most challenging neurodegenerative diseases to treat, with decades of clinical failures shaping how biotech companies have learned to be cautious ...